Twocases of lung carcinoma with osteoplastic bone metastasis are reported. The bone roentgenogram of a 66-year-old womanwith pleuritis carcinomotosa revealed multiple sclerotic changes in the right forearm, lumbar spine, and pelvis. Biopsy at internal fixation of the left humerusrevealed metastatic adenocarcinomawith osteoplastic change. In a 77-year-old manwith small cell carcinoma of the lung, after chemotherapy, osteoplastic bone changes were detected in roentgenograms. An ivory vertebra formation was seen in LI, L2 and L4, and bone scintigram showed, additionally, uptake in the ilium. (Internal Medicine 32: 416-420, 1993) 
Introduction
Metastasis to bone is not uncommonwith lung cancers. In the literature, the incidence of bone metastasis varies from 1 5.7 to 51 percent (1, 2) . Whereas the incidence of osteolytic metastasis is frequent, osteoplastic bone lesions are rare (3-1 1 ). Wepresent here two cases ofosteoplastic bone metastasis from bronchogenic carcinoma.
Case Report

Case1
A 66-year-old womanwas admitted to our hospital with a three-month history of right forearm pain and swelling; she also hadright iliac pain. She had no cough, dyspnea, orcyanosis. She had been in good health, and her past medical history was unremarkable, except for hysterotomy because of uterine myoma. She was a non-smoker. There was no family history of neoplasms. Physical examination showed a fairly well nourished woman,whoseright forearm was swollen with slight tenderness. Decreased breath sounds were audible over the left posterior lower chest. An enlargement of the thyroid gland, lymphadenopathy and hepatosplenomegaly were absent. The neurologic findings were normal except for decreased deep tendon reflexes.
A chest roentgenogram revealed a large left pleural effusion (Fig. 1) . Cytology of the effusion showed an adenocarcinoma. Chest CT scan after thoracic drainage revealed a nodule, 2.0 cm in diameter, with spiculated, irregular margins in the left posterior basal segment, and invasion ofmediastinal lymphnodes (Fig. 2) . Retrospectively, the nodule was identified in a screening chest roentgenogram of two years previously; the nodule had increased slightly in a roentgenogram of one year later. Laboratory investigation revealed an erythrocyte sedimentation rate of78 mmin the first hour. The hemoglobin was 13.2 g/dl, WBC10,400/mm3 with 65% neutrophils, and platelets were 415,000/mm3. Fasting blood sugar was 202 mg/ml, HbAj 13.3%, HbAjC 10.5%, and urine sugar was 2.1 g/dl. Serum calcium and phosphorus levels were normal. Serum level of parathormone was 610 pg/ml, and l,25(OH)2Vit.D, 33 pg/ml. LDH was 1,298 IU/1, and alkaline phosphatase (ALP), 3,372 IU/1 with 85% of ALP3 isozyme. CEA levels were 99.9 ng/ml in blood, and 42.3 ng/ml in the effusion, and neuron-specific enolase (NSE) was 13 ng/ml.
Bone roentgenograms revealed multiple sclerotic changes, especially in the right forearm, lumbar spine, and pelvis ( Fig. 3a and 3b). Bone scintigram also showed multiple uptake (Fig. 4) . CDDPat 150 mg and OK432at 6.0 KE were administered intrathoracically after thoracic drainage. While at homeshe experienced progressive anorexia and malaise. After four months, pathological bone fracture of the left arm was detected.
Lung Cancer with Osteoplastic Bone Metastasis osteoplastic bone metastasis (Fig. 5) .
lumbago. His chest roentgenogram revealed a mass-like shadow in the left anteriorbasal segment (Fig. 6 ). The diagnosis of small Case 2 cell carcinoma was made by aspiration lung biopsy. The NSE A 77-year-old man was admitted to our hospital because of level was 40 ng/ml. Before treatment, bone roentgenograms were normal, but a bone scintigram showed multiple uptake in the spine (L4). As the possibility of bone metastasis was not ruled out, a combination chemotherapy of carboplatin and etoposide was performed. After four courses of chemotherapy, the mass-like shadow had almost disappeared, but osteoplastic changes were detected in roentgenograms. An ivory vertebra formation was seen in the LI, L2 and L4 (Fig. 7) , and bone scintigram showed, additionally, uptake in the ilium (Fig. 8) . Therate ofmetastasis to bone has been shownat autopsy to be as high as 83.3 percent inprostate, 61. 1 percentin breast, and 51.1 percent in lung cancer (1) . In women, the most frequent origin of metastatic carcinoma is carcinoma of the breast, followed by carcinoma of the lung. In men, carcinoma of the lung is the most frequent cause of metastatic bone disease (1).
Tumorcells which enter the circulation are carried to the vascular bone marrow. This is followed by invasion of the bone tissue matrix, and finally by invasion of the cortical bone ( 12) .
It is known that bone itself contains growth factors and angiogenesis factors, such as fibroblast growth factor, plateletderived growth factor, transforming growth factor beta and insulin-like growth factors I and II, each of which is important for the local growth of the tumor (13) . Although most carcinomastend to cause osteolytic metastasis, prostate cancer and breast cancer occasionally provokeosteoplastic metastasis in the affected bone, producing an increase in osseous density on the radiograph. In prostate cancer extracts , osteoblast stimulatory factors were found which could be responsible for the stimulation of new bone formation (13) . Whereas osteolytic metastasis is frequent in lung cancers, 26 cases (including our two cases) of osteoplastic metastasis from primary bronchogenic carcinomas have been reported by several authors (3-1 1). Of these cases, 13 were adenocarcinomas, 9 were small-cell carcinomas, 3 wereanaplastic, and one wasa large-cell carcinoma (Table 1) . It is notable that osteoplastic bone metastasis was not seen in squamous-cell carcinoma of the lung. Elaboration of a parathyroid hormone-related protein, which stimulates osteoclastic bone resorption in vitro and in vivo, wasconfirmed in a squamous-cell carcinomaof the lung (14) . This fact leads one to speculate that the production of parathyroid hormone-related protein may account for the apparent lack ofosteoplastic lesions in this tumor (6, 9) . However, recent clinical studies of serum parathyroid hormone-related protein level in patients with lung cancer support the view that a wide variety of cell types can produce parathyroid hormonerelated protein ( 1 5) . Histochemical study using anti-parathyroid hormone-related protein antibody also revealed that all lung cancer cell types produce parathyroid hormone-related protein (Sakamoto et al., unpublished observation). Nevertheless, further investigation is needed to determine whether parathyroid hormone-related protein molecule has not only immunologically reactivity but also biologically activity. The roentgenographic appearance of the bone lesions in case 2 was indistinguishable from those due to metastasis from prostatic cancer. Histologic examination of the bone lesion was not performed, but a primary carcinoma of the prostate was considered unlikely based on the following findings: 1) normal size, shape and consistency of the prostate and 2) normal levels of serum acid phosphatase. The treatment of skeletal metastasis from a primary lung cancer depends on the patient's general condition, the radiosensitivity of the lesion, the site and extent of the involvement, and the proximity of the tumor to vital organs such as the spinal cord. Most skeletal metastasis of pulmonary carcinomas are radiosensitive and a partial response can be achieved in some patients by radiation therapy (1 , 2).
